Simba Gill's Insider Trades & SAST Disclosures
Simba Gill's most recent trade in Evelo Biosciences Inc was a trade of 1,171 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 7, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Simba Gill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,171 | 16,408 | - | - | Restricted Stock Units | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,171 | 4,096 (0%) | 0% | - | Common Stock | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 9.51 per share. | 07 Aug 2023 | 342 | 3,754 (0%) | 0% | 9.5 | 3,252 | Common Stock |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.13 per share. | 08 May 2023 | 3,537 | 58,512 (0%) | 0% | 0.1 | 444 | Common Stock |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 23,437 | 351,563 | - | - | Restricted Stock Units | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 1,125,000 | 1,125,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 375,000 | 375,000 | - | - | Restricted Stock Units | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Simba Gill | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges